ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
US Tech 100
18,244.80
0.27%
Dow Jones
39,872.99
0.17%
Brent Oil
82.11
-0.41%
Bitcoin
69,853.82
-0.40%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/22/20241:33AMAlliance NewsAlliance NewsGET READY: British Land, Close Brothers, M&S, RS, SSE at 0700 BST
05/22/20241:31AMAlliance NewsAlliance NewsAlliance News UK - start of day
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentLSE:AALBAalberts
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesLSE:0RADOse Immunotherapeutics Sa
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentEU:AALBAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesTG:6OPOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseasesEU:OSEOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesLSE:0RADOse Immunotherapeutics Sa
05/22/20241:30AMGlobeNewswire Inc.Aalberts N.V.: Aalberts sustained added value margin in challenging market environmentTG:AACAAalberts NV
05/22/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliquesTG:6OPOSE Immunotherapeutics
05/22/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.Nextensa offers its shareholders an optional dividendEU:NEXTANextensa SA
05/22/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
05/22/20241:30AMGlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelLSE:0NUTNextensa
05/22/20241:30AMGlobeNewswire Inc.Nextensa offers its shareholders an optional dividendLSE:0NUTNextensa
05/22/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
05/22/20241:30AMGlobeNewswire Inc.Nextensa propose à ses actionnaires un dividende optionnelEU:NEXTANextensa SA
05/22/20241:30AMGlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
05/22/20241:25AMGlobeNewswire Inc.Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, BelgiumNYSE:BHPBHP Group Limited
05/22/20241:16AMBusiness WireHAFNIA LIMITED: Ex-Dividend USD 0.3443 TodayNYSE:HAFNHafnia Ltd
05/22/20241:06AMAlliance NewsAlliance NewsJapan's trade deficit widens in April, as export growth falls short
05/22/20241:05AMBusiness WireKey Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)NYSE:CLCOCool Company LTD
05/22/20241:00AMBusiness WireWolters Kluwer lance Twinfield DossierFlow aux Pays-Bas, pour aider les comptables à rationaliser la collecte d'informations sur les clients
05/22/20241:00AMGlobeNewswire Inc.Start of Day Message
05/22/20241:00AMGlobeNewswire Inc.Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
05/22/20241:00AMBusiness WireCTP to build specialist healthy dog food facility for PsiBufet and Butternut Box at CTPark Zabrze in Poland

Your Recent History

USOTC
IBGR
Nexus Energy Services (PK)
USOTC
QEDN
QED Connect (PK)
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
LWLG
Lightwave Logic
USOTC
DPLS
DarkPulse (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CNNA
Cann American (CE)
USOTC
GDVM
Global Developments (PK)
NASDAQ
TSLA
Tesla
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
TLRY
Tilray Brands
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved